Innovation at Nîmes University Hospital: a new technique for treating pulmonary embolism

Innovation at Nîmes University Hospital: a new technique for treating pulmonary embolism

Le Dr Pierre Robert et le Pr Benoît Lattuca, cardiologues interventionnels au CHU de Nîmes

L’équipe de cardiologie interventionnelle du CHU propose une nouvelle technique pour l’embolie pulmonaire grave. Une innovation qui permet un traitement le plus individualisé possible.

Pulmonary embolism is a common pathology (around 100,000 patients per year in France) linked to the presence of blood clots obstructing the pulmonary arteries, causing rapid breathing difficulties and potential long-term sequelae. With a risk of death of 5% in the first month and up to 30% for the most serious forms.

The recommended treatment until now was to take anticoagulants to "dissolve" these clots with variable results depending on the severity of the pathology.

A new targeted and urgently accessible technique

In addition to medical treatment, there are now two different techniques for removing the clot located between the heart and lungs under local anesthesia from a puncture of a vein: one one allowing the aspiration of the clot (thrombectomy) and the other the use of ultrasound directly in the pulmonary artery to facilitate its dissolution (thrombolysis in situ). "This is a real breakthrough for patients. The first international registers highlighting a significant reduction in mortality with a risk of death up to ten times lower for the most serious forms, compared to conventional treatment, < /em> explains Professor Benoît Lattuca, cardiologist at Nîmes University Hospital.

The Nîmes University Hospital is one of the rare French centers to have acquired these two techniques with a complete therapeutic arsenal allowing the most individualized treatment possible.

Easy support

A specific care pathway combining a multidisciplinary assessment has at the same time been set up to offer these techniques in a regional care network and allow the greatest number of patients to benefit from them from ’ specific funding allocated by the Nîmes University Hospital for these innovations.

Based on published scientific data, the High Authority of Health validated on January 26, 2024 the therapeutic impact and reimbursement of pulmonary thrombectomy, which should make it possible to offer this technique even more widely to the population.

"The cardiology team at Nîmes University Hospital has been practicing these techniques for more than a year with numerous interventions carried out and at the same time participates in their development via communications at congresses, the training of practitioners from other centers to best disseminate the techniques and by continuing research in this area with upcoming participation in two international studies on these techniques, concludes Professor Lattuca.

Add a Comment

Your email address will not be published. Required fields are marked *

(function(d,s){d.getElementById("licnt2061").src= "https://counter.yadro.ru/hit?t44.6;r"+escape(d.referrer)+ ((typeof(s)=="undefined")?"":";s"+s.width+"*"+s.height+"*"+ (s.colorDepth?s.colorDepth:s.pixelDepth))+";u"+escape(d.URL)+ ";h"+escape(d.title.substring(0,150))+";"+Math.random()}) (document,screen)